Ron Cohen

Track

Insider profile

Currently holds a position at Acorda Therapeutics Inc

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 11% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President,Chief Executive Officer, Director Acorda Therapeutics Inc None -
Independent Director Dyax Corp Nov. 1, 2011 - Jan. 22, 2016
Ron Cohen's trades of Acorda Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
203.17
Quantity 98,226 +49.6%
Value US$1,194,467
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-20 2023-03-17
B Purchase
98,226 +49.6%
203.17
US$1,194,467 		98,226 +49.6% 203.17 US$1,194,467
2023-03-20 2023-03-16
B Purchase
14,439 +0.2%
300.78
US$920,858 		14,439 +0.2% 300.78 US$920,858
2022-03-21 2022-03-17
S Sale
14,723 +42.2%
473.05
US$4,714,984 		14,723 +42.2% 473.05 US$4,714,984